← Leaderboards
Theo Hagg
University Of Louisville
$10,681,523
Attributed
$12,332,380
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $899.9K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$12,332,380 · 5
By mechanism
R01$11,673,124 · 3
R21$357,500 · 1
U01$301,756 · 1
Top collaborators
- Scott Whittemore7 shared
Most similar at University Of Louisville
Same institution · by research overlap
- Michal Hetman$7,254,903
- Jun Yan$16,605,525
- Juliane I Beier$3,751,134
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMediatingNervous System DisorderStrokeAcutePharmaceutical PreparationsSignal PathwayBrainIntegrinsGrantIn VitroTissuesInflammationReceptorMiddle Cerebral Artery OcclusionGeneticMolecular TargetCytokineAdultAffectSignal TransductionPlayLigandsBlood
Grant awards (35)
Targeting CNTF to increase adult forebrain neurogenesis$428,670
R01 · FY2024 · AG · contact PI
Targeting CNTF to increase adult forebrain neurogenesis$428,670
R01 · FY2023 · AG · contact PI
Translational assessment of an FAK inhibitor for acute cerebroprotection$301,756
U01 · FY2023 · NS · contact PI
Targeting CNTF to increase adult forebrain neurogenesis$428,670
R01 · FY2022 · AG · contact PI
Targeting blood-derived integrin signaling after stroke$323,750
R01 · FY2022 · NS · contact PI
Targeting CNTF to increase adult forebrain neurogenesis$428,670
R01 · FY2021 · AG · contact PI
Targeting blood-derived integrin signaling after stroke$323,750
R01 · FY2021 · NS · contact PI
Targeting CNTF to increase adult forebrain neurogenesis$428,670
R01 · FY2020 · AG · contact PI
Targeting blood-derived integrin signaling after stroke$323,750
R01 · FY2020 · NS · contact PI
Targeting blood-derived integrin signaling after stroke$320,873
R01 · FY2019 · NS · contact PI
Targeting blood-derived integrin signaling after stroke$321,135
R01 · FY2018 · NS · contact PI
Targeting CNTF to increase adult forebrain neurogenesis$299,300
R01 · FY2018 · AG · contact PI
Targeting CNTF to increase adult forebrain neurogenesis$299,300
R01 · FY2017 · AG · contact PI
Targeting CNTF to increase adult forebrain neurogenesis$299,300
R01 · FY2016 · AG · contact PI
Vascular responses as therapeutic targets after SCI$426,017
R01 · FY2015 · NS
Targeting CNTF to increase adult forebrain neurogenesis$290,321
R01 · FY2015 · AG · contact PI
Vascular responses as therapeutic targets after SCI$421,755
R01 · FY2014 · NS
Targeting CNTF to increase adult forebrain neurogenesis$299,300
R01 · FY2014 · AG · contact PI
Vascular responses as therapeutic targets after SCI$411,111
R01 · FY2013 · NS
Vascular responses as therapeutic targets after SCI$426,020
R01 · FY2012 · NS · contact PI
Vascular responses as therapeutic targets after SCI$423,415
R01 · FY2011 · NS · contact PI
Targeting CNTF to increase adult forebrain neurogenesis$282,938
R01 · FY2011 · AG · contact PI
Vascular responses as therapeutic targets after SCI$605,517
R01 · FY2010 · NS · contact PI
Targeting CNTF to increase adult forebrain neurogenesis$294,359
R01 · FY2010 · AG · contact PI
Vascular responses as therapeutic targets after SCI$587,880
R01 · FY2009 · NS · contact PI
Targeting CNTF to increase adult forebrain neurogenesis$297,332
R01 · FY2009 · AG · contact PI
Vascular responses as therapeutic targets after SCI$321,990
R01 · FY2008 · NS · contact PI
Targeting CNTF to increase adult forebrain neurogenesis$297,332
R01 · FY2008 · AG · contact PI
Vascular responses as therapeutic targets after SCI$321,990
R01 · FY2007 · NS · contact PI
Targeting CNTF to increase adult forebrain neurogenesis$303,400
R01 · FY2007 · AG · contact PI
Vascular responses as therapeutic targets after SCI$331,607
R01 · FY2006 · NS · contact PI
Vascular responses as therapeutic targets after SCI$336,780
R01 · FY2005 · NS
Vascular responses as therapeutic targets after SCI$339,552
R01 · FY2004 · NS
PTP identity and inhibition for nigrostriatal protection$178,750
R21 · FY2003 · NS
PTP identity and inhibition for nigrostriatal protection$178,750
R21 · FY2002 · NS